DAPSONE\FERROUS OXALATE: 69 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
69
Total FAERS Reports
2 (2.9%)
Deaths Reported
50
Hospitalizations
69
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20110630 · Latest Report: 20241110
What Are the Most Common DAPSONE\FERROUS OXALATE Side Effects?
#1 Most Reported
Foetal growth restriction
12 reports (17.4%)
#2 Most Reported
Autism spectrum disorder
12 reports (17.4%)
#3 Most Reported
Preterm premature rupture of membranes
9 reports (13.0%)
All DAPSONE\FERROUS OXALATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Autism spectrum disorder | 12 | 17.4% | 0 | 12 |
| Foetal growth restriction | 12 | 17.4% | 0 | 12 |
| Preterm premature rupture of membranes | 9 | 13.0% | 0 | 9 |
| Foetal exposure during pregnancy | 7 | 10.1% | 0 | 7 |
| Hypoalbuminaemia | 7 | 10.1% | 0 | 7 |
| Maternal exposure during pregnancy | 7 | 10.1% | 0 | 7 |
| Oedema peripheral | 7 | 10.1% | 0 | 7 |
| Off label use | 7 | 10.1% | 0 | 5 |
| Thrombotic microangiopathy | 7 | 10.1% | 0 | 0 |
| Low birth weight baby | 6 | 8.7% | 0 | 6 |
| Premature baby | 6 | 8.7% | 0 | 6 |
| Agranulocytosis | 5 | 7.3% | 0 | 5 |
| Drug reaction with eosinophilia and systemic symptoms | 5 | 7.3% | 2 | 4 |
| Haemolytic anaemia | 5 | 7.3% | 0 | 3 |
| Methaemoglobinaemia | 5 | 7.3% | 0 | 3 |
Who Reports DAPSONE\FERROUS OXALATE Side Effects? Age & Gender Data
Gender: 40.0% female, 60.0% male. Average age: 56.7 years. Most reports from: FR. View detailed demographics →
Is DAPSONE\FERROUS OXALATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 8 | 2 | 6 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 5 | 0 | 4 |
| 2019 | 5 | 0 | 3 |
| 2020 | 18 | 0 | 11 |
| 2021 | 1 | 0 | 1 |
| 2023 | 5 | 0 | 3 |
| 2024 | 5 | 0 | 5 |
What Is DAPSONE\FERROUS OXALATE Used For?
| Indication | Reports |
|---|---|
| Pemphigoid | 17 |
| Leprosy | 15 |
| Immune thrombocytopenia | 10 |
Official FDA Label for DAPSONE\FERROUS OXALATE
Official prescribing information from the FDA-approved drug label.